Suppression of myocardial ischemia-reperfusion injury by inhibitors of cytochrome P450 in rats

European Journal of Pharmacology

Volumn 611, Issue 1-3, 2009, Pages 64-71

  Ishihara, Yasuhiro ^a   Sekine, Masaya ^a   Nakazawa, Mikio ^b   Shimamoto, Norio ^a  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b Faculty of Medicine   (Japan)

Author keywords

Cytochrome P450; Heart; Ischemia; Reactive oxygen species; Reperfusion; Sulfaphenazole

Indexed keywords

CIMETIDINE; CYTOCHROME P450; CYTOCHROME P450 INHIBITOR; LIPID PEROXIDE; REACTIVE OXYGEN METABOLITE; SULFAPHENAZOLE; TESTOSTERONE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BRAIN INFARCTION SIZE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFECT; ENZYME INHIBITION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART RATE; HEART WEIGHT; LIPID PEROXIDATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TESTOSTERONE METABOLISM;

ANIMALS; BODY WEIGHT; CIMETIDINE; CORONARY VESSELS; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; HEART; LIPID PEROXIDATION; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; ORGAN SIZE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SULFAPHENAZOLE;

EID: 67349246440     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.03.069     Document Type: Article

References (38)

1. Albertine K.H., Weyrich A.S., Ma X.L., Lefer D.J., Becker L.C., and Lefer A.M. Quantification of neutrophil migration following myocardial ischemia and reperfusion in cats and dogs. J. Leukoc. Biol. 55 (1994) 557-566
2. Apple F.S. Acute myocardial infarction and coronary reperfusion. Serum cardiac markers for the 1990s. Am. J. Clin. Pathol. 97 (1992) 217-226
3. Becker L.B. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc. Res. 61 (2004) 461-470
4. Bondy S.C., and Naderi S. Contribution of hepatic cytochrome P450 systems to the generation of reactive oxygen species. Biochem. Pharmacol. 48 (1994) 155-159
5. Chen J.X., Zeng H., Tuo O.H., Yu H., Meyrick B., and Aschner J.L. NADPH oxidase modulates myocardial Akt, ERK1/2 activation, and angiogenesis after hypoxia-reoxygenation. Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H1664-H1674
6. Dreyer W.J., Michael L.H., West M.S., Smith C.W., Rothlein R., Rossen R.D., Anderson D.C., and Entman M.L. Neutrophil accumulation in ischemic canine myocardium. Insights into time course, distribution, and mechanism of localization during early reperfusion. Circulation 84 (1991) 400-411
7. Gonzalez F.J. The molecular biology of cytochrome P450s. Pharmacol. Rev. 40 (1988) 243-288
8. Granville D.J., Tashakkor B., Takeuchi C., Gustafsson A.B., Huang C., Sayen M.R., Wentworth Jr. P., Yeager M., and Gottlieb R.A. Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 1321-1326
9. Guengerich F.P., and Mason P.S. Immunological comparison of hepatic and extrahepatic cytochromes P-450. Mol. Pharmacol. 15 (1979) 154-164
10. Ishihara Y., Shiba D., and Shimamoto N. Enhancement of DMNQ-induced hepatocyte toxicity by cytochrome P450 inhibition. Toxicol. Appl. Pharmacol. 214 (2006) 109-117
11. Janero D.R., Burghardt B., Lopez R., and Cardell M. Influence of cardioprotective cyclooxygenase and lipoxygenase inhibitors on peroxidative injury to myocardial-membrane phospholipid. Biochem. Pharmacol. 38 (1989) 4381-4387
12. Jordan J.E., Zhao Z.Q., and Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc. Res. 43 (1999) 860-878
13. Kato K., Terao S., Shimamoto N., and Hirata M. Studies on scavengers of active oxygen species. 1. Synthesis and biological activity of 2-O-alkylascorbic acids. J. Med. Chem. 31 (1988) 793-798
14. Khan M., Mohan I.K., Kutala V.K., Kumbala D., and Kuppusamy P. Cardioprotection by sulfaphenazole, a cytochrome P450 inhibitor: mitigation of ischemia-reperfusion injury by scavenging of reactive oxygen species. J. Pharmacol. Exp. Ther. 323 (2007) 813-821
15. Kloner R.A., Przyklenk K., and Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues. Circulation 80 (1989) 11151127
16. Laurindo F.R., Fernandes D.C., and Santos C.X. Assessment of superoxide production and NADPH oxidase activity by HPLC analysis of dihydroethidium oxidation products. Methods Enzymol. 441 (2008) 237-260
17. Levraut J., Iwase H., Shao Z.H., Vanden Hoek T.L., and Schumacker P.T. Cell death during ischemia: relationship to mitochondrial depolarization and ROS generation. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) H549-H558
18. Loida P.J., and Sligar S.G. Molecular recognition in cytochrome P-450: mechanism for the control of uncoupling reactions. Biochemistry 32 (1993) 11530-11538
19. Mitsuda M., Iwasaki M., and Asahi S. Cynomolgus monkey cytochrome P450 2C43: cDNA cloning, heterologous expression, purification and characterization. J. Biochem. 139 (2006) 865-872
20. Nieto N., Friedman S.L., and Cederbaum A.I. Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species. Hepatology 35 (2002) 62-73
21. O'Brien P.J. Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity. Toxicology 245 (2008) 206-218
22. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979) 351-358
23. Puntarulo S., and Cederbaum A.I. Effect of oxygen concentration on microsomal oxidation of ethanol and generation of oxygen radicals. Biochem. J. 251 (1988) 787-794
24. Rashba-Step J., and Cederbaum A.I. Generation of reactive oxygen intermediates by human liver microsomes in the presence of NADPH or NADH. Mol. Pharmacol. 45 (1994) 150-157
25. Raza H., Prabu S.K., Robin M.A., and Avadhani N.G. Elevated mitochondrial cytochrome P450 2E1 and glutathione S-transferase A4-4 in streptozotocin-induced diabetic rats: tissue-specific variations and roles in oxidative stress. Diabetes 53 (2004) 185-194
26. Rochitte C.E., Lima J.A., Bluemke D.A., Reeder S.B., McVeigh E.R., Furuta T., Becker L.C., and Melin J.A. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation 98 (1998) 1006-1014
27. Roman R.J. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol. Rev. 82 (2002) 131-185
28. Shahabi H.N., Andersson D.R., and Nissbrandt H. Cytochrome P450 2E1 in the substantia nigra: relevance for dopaminergic neurotransmission and free radical production. Synapse 62 (2008) 379-388
29. Tada H., Kutsumi Y., Misawa T., Shimamoto N., Nakai T., and Miyabo S. Effects of pretreatment with 2-O-octadecylascorbic acid, a novel free radical scavenger, on reperfusion-induced arrhythmias in isolated perfused rat hearts. J. Cardiovasc. Pharmacol. 16 (1990) 984-991
30. Tao L., Gao E., Jiao X., Yuan Y., Li S., Christopher T.A., Lopez B.L., Koch W., Chan L., Goldstein B.J., and Ma X.L. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 115 (2007) 1408-1416
31. Thompson-Gorman S.L., and Zweier J.L. Evaluation of the role of xanthine oxidase in myocardial reperfusion injury. J. Biol. Chem. 265 (1990) 6656-6663
32. Thum T., and Borlak J. Cytochrome P450 mono-oxygenase gene expression and protein activity in cultures of adult cardiomyocytes of the rat. Br. J. Pharmacol. 130 (2000) 1745-1752
33. Thum T., and Borlak J. Testosterone, cytochrome P450, and cardiac hypertrophy. FASEB J. 16 (2002) 1537-1549
34. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc. Res. 61 (2004) 481-497
35. Watanabe T., Suzuki N., Shimamoto N., Fujino M., and Imada A. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ. Res. 69 (1991) 370-377
36. Zangar R.C., Davydov D.R., and Verma S. Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol. Appl. Pharmacol. 199 (2004) 316-331
37. Zhao Z.Q., Corvera J.S., Halkos M.E., Kerendi F., Wang N.P., Guyton R.A., and Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H579-H588
38. Zhao X., Chen Y.R., He G., Zhang A., Druhan L.J., Strauch A.R., and Zweier J.L. Endothelial nitric oxide synthase (NOS3) knockout decreases NOS2 induction, limiting hyperoxygenation and conferring protection in the postischemic heart. Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H1541-H1550